204 related articles for article (PubMed ID: 12890376)
1. Epstein-Barr virus encoded latent membrane protein 1 induces TRAF1 expression to promote anti-apoptosis activity via NF-kappaB signaling pathway in nasopharyngeal carcinoma.
Wang C; Ai M; Ren W; Xiao H; Li X; Tang F; Gu H; Yi W; Weng X; Deng X; Cao Y
Chin Med J (Engl); 2003 Jul; 116(7):1022-8. PubMed ID: 12890376
[TBL] [Abstract][Full Text] [Related]
2. [Matrix metalloproteinase 9 expression is induced by Epstein-Barr virus LMP1 via NF-kappa B or AP-1 signaling pathway in nasopharyngeal carcinoma cells].
Wang C; Deng X; Li X; Gu H; Yi W; Weng X; Xia L; Cao Y
Zhonghua Zhong Liu Za Zhi; 2002 Jan; 24(1):9-13. PubMed ID: 11977651
[TBL] [Abstract][Full Text] [Related]
3. [EBV latent membrane protein 1 induces p53 expression via NF-kappa B in nasopharyngeal carcinoma].
Liao W; Tang M; Yin L
Zhonghua Zhong Liu Za Zhi; 2001 May; 23(3):199-201. PubMed ID: 11783085
[TBL] [Abstract][Full Text] [Related]
4. Epstein-Barr virus-encoded LMP1 and CD40 mediate IL-6 production in epithelial cells via an NF-kappaB pathway involving TNF receptor-associated factors.
Eliopoulos AG; Stack M; Dawson CW; Kaye KM; Hodgkin L; Sihota S; Rowe M; Young LS
Oncogene; 1997 Jun; 14(24):2899-916. PubMed ID: 9205097
[TBL] [Abstract][Full Text] [Related]
5. Epstein-Barr virus (EBV) latent membrane protein 1 induces interleukin-8 through the nuclear factor-kappa B signaling pathway in EBV-infected nasopharyngeal carcinoma cell line.
Ren Q; Sato H; Murono S; Furukawa M; Yoshizaki T
Laryngoscope; 2004 May; 114(5):855-9. PubMed ID: 15126743
[TBL] [Abstract][Full Text] [Related]
6. Expression of tumor necrosis factor receptor-associated factor 1 in nasopharyngeal carcinoma: possible upregulation by Epstein-Barr virus latent membrane protein 1.
Siegler G; Meyer B; Dawson C; Brachtel E; Lennerz J; Koch C; Kremmer E; Niedobitek E; Gonnella R; Pilch BZ; Young LS; Niedobitek G
Int J Cancer; 2004 Nov; 112(2):265-72. PubMed ID: 15352039
[TBL] [Abstract][Full Text] [Related]
7. Epstein-barr virus latent membrane protein 1 induces and causes release of fibroblast growth factor-2.
Wakisaka N; Murono S; Yoshizaki T; Furukawa M; Pagano JS
Cancer Res; 2002 Nov; 62(21):6337-44. PubMed ID: 12414666
[TBL] [Abstract][Full Text] [Related]
8. Epstein-Barr virus latent membrane protein 1 (LMP1) upregulates Id1 expression in nasopharyngeal epithelial cells.
Li HM; Zhuang ZH; Wang Q; Pang JC; Wang XH; Wong HL; Feng HC; Jin DY; Ling MT; Wong YC; Eliopoulos AG; Young LS; Huang DP; Tsao SW
Oncogene; 2004 May; 23(25):4488-94. PubMed ID: 15064751
[TBL] [Abstract][Full Text] [Related]
9. [Effect of Epstein-Barr virus latent membrane protein 1 (LMP1) on apoptosis of nasopharyngeal carcinoma cell line CNE1].
Chen Y; Chen XY
Ai Zheng; 2002 May; 21(5):498-503. PubMed ID: 12452040
[TBL] [Abstract][Full Text] [Related]
10. Latent membrane protein 1 suppresses RASSF1A expression, disrupts microtubule structures and induces chromosomal aberrations in human epithelial cells.
Man C; Rosa J; Lee LT; Lee VH; Chow BK; Lo KW; Doxsey S; Wu ZG; Kwong YL; Jin DY; Cheung AL; Tsao SW
Oncogene; 2007 May; 26(21):3069-80. PubMed ID: 17099724
[TBL] [Abstract][Full Text] [Related]
11. Induction of receptor for advanced glycation end products by EBV latent membrane protein 1 and its correlation with angiogenesis and cervical lymph node metastasis in nasopharyngeal carcinoma.
Tsuji A; Wakisaka N; Kondo S; Murono S; Furukawa M; Yoshizaki T
Clin Cancer Res; 2008 Sep; 14(17):5368-75. PubMed ID: 18765528
[TBL] [Abstract][Full Text] [Related]
12. Telomerase activation by Epstein-Barr virus latent membrane protein 1 is associated with c-Myc expression in human nasopharyngeal epithelial cells.
Yang J; Deng X; Deng L; Gu H; Fan W; Cao Y
J Exp Clin Cancer Res; 2004 Sep; 23(3):495-506. PubMed ID: 15595642
[TBL] [Abstract][Full Text] [Related]
13. Upregulated expression of kappa light chain by Epstein-Barr virus encoded latent membrane protein 1 in nasopharyngeal carcinoma cells via NF-kappaB and AP-1 pathways.
Liu HD; Zheng H; Li M; Hu DS; Tang M; Cao Y
Cell Signal; 2007 Feb; 19(2):419-27. PubMed ID: 16979873
[TBL] [Abstract][Full Text] [Related]
14. Decoy receptor 3, upregulated by Epstein-Barr virus latent membrane protein 1, enhances nasopharyngeal carcinoma cell migration and invasion.
Ho CH; Chen CL; Li WY; Chen CJ
Carcinogenesis; 2009 Aug; 30(8):1443-51. PubMed ID: 19483191
[TBL] [Abstract][Full Text] [Related]
15. Frequent expression of the tumor necrosis factor receptor-associated factor 1 in latent membrane protein 1-positive posttransplant lymphoproliferative disease and HIV-associated lymphomas.
Murray PG; Swinnen LJ; Flavell JR; Ragni MV; Baumforth KR; Toomey SM; Filipovich AH; Lowe D; Schnell CS; Johl J; Gulley M; Young LS; Ambinder RF
Hum Pathol; 2001 Sep; 32(9):963-9. PubMed ID: 11567226
[TBL] [Abstract][Full Text] [Related]
16. Epstein-Barr virus latent membrane protein 1 modulates epidermal growth factor receptor promoter activity in a nuclear factor kappa B-dependent manner.
Tao YG; Tan YN; Liu YP; Song X; Zeng L; Gu HH; Tang M; Li W; Yi W; Cao Y
Cell Signal; 2004 Jul; 16(7):781-90. PubMed ID: 15115657
[TBL] [Abstract][Full Text] [Related]
17. Epstein-Barr virus LMP1 modulates the malignant potential of gastric carcinoma cells involving apoptosis.
Sheu LF; Chen A; Wei YH; Ho KC; Cheng JY; Meng CL; Lee WH
Am J Pathol; 1998 Jan; 152(1):63-74. PubMed ID: 9422524
[TBL] [Abstract][Full Text] [Related]
18. The NPC derived C15 LMP1 protein confers enhanced activation of NF-kappa B and induction of the EGFR in epithelial cells.
Miller WE; Cheshire JL; Baldwin AS; Raab-Traub N
Oncogene; 1998 Apr; 16(14):1869-77. PubMed ID: 9583684
[TBL] [Abstract][Full Text] [Related]
19. Heterodimer formation between c-Jun and Jun B proteins mediated by Epstein-Barr virus encoded latent membrane protein 1.
Song X; Tao YG; Deng XY; Jin X; Tan YN; Tang M; Wu Q; Lee LM; Cao Y
Cell Signal; 2004 Oct; 16(10):1153-62. PubMed ID: 15240010
[TBL] [Abstract][Full Text] [Related]
20. Induction of matrix metalloproteinases by Epstein-Barr virus latent membrane protein 1 isolated from nasopharyngeal carcinoma.
Lee DC; Chua DT; Wei WI; Sham JS; Lau AS
Biomed Pharmacother; 2007 Oct; 61(9):520-6. PubMed ID: 17913445
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]